Can a sharper scan spot wrist fractures faster?
NCT ID NCT03899025
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This pilot study tests whether a high-resolution CT scan (HRpQCT) can improve the diagnosis of scaphoid fractures, a common wrist injury in young adults. Participants with a suspected scaphoid fracture will receive both a standard CT and an HRpQCT scan to compare accuracy. The goal is to see if the sharper imaging can detect fractures more reliably and potentially speed up diagnosis, reducing overtreatment and long-term complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-resolution peripheral quantitative computed tomography (HRpQCT) scan of the hand/wrist
- What this could lead to
- If HRpQCT proves accurate, it could enable faster, more precise diagnosis of scaphoid fractures, reducing unnecessary immobilization and improving outcomes.
- What could go wrong
- This is a small pilot study, so results may not be conclusive. HRpQCT is not widely available, and its benefit over standard CT is unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
91 people
The number who actually took part.
- Started
-
Dec 2017
- Finished
-
Apr 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Phase I - Diagnostic phase Inclusion criteria In order to be eligible to participate in Phase I of the study, a subject must meet all of the following criteria: 1. Adults (18 years or older) who visit the emergency department of the VieCuri Medical Center Venlo with a clinically suspected scaphoid fracture due to a trauma (\<1 week after trauma). 2. Patients who understand the conditions of the study and are willing and able to comply with the scheduled radiographic evaluations and the prescribed treatment and rehabilitation. 3. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion. Exclusion criteria A potential subject who meets the following criterion will be excluded from participation in this study: 1. Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule. 2. Patients with a scaphoid fracture at the ipsilateral side in medical history 3. Pregnancy. Phase II - Follow-up phase Inclusion criteria In order to be eligible to participate in Phase II of the study, a subject must meet all of the following criteria: 1. Patients who completed Phase I of the study and have a radiographically confirmed scaphoid fracture on CT or HR-pQCT. 2. Patients who signed the Ethics Committee approved specific informed consent form prior to inclusion. 3. Conservatively treated scaphoid fractures. Exclusion criteria A potential subject who meets the following criterion will be excluded from participation in this study: 1. Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule. 2. Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Scafoïd; fracture are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VieCuri Medical Centre
Venlo, Limburg, 5912, Netherlands